Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq:
TMDI), a medical device company focused on the design, development
and commercialization of a robotic surgical system for application in
minimally invasive surgery (“MIS”), announces that David McNally,
President and CEO of Titan Medical, will present in the plenary session
titled “Innovations in Robotic Technologies, What The Future Holds In
Store” on Thursday, June 20 at the Society of Robotic Surgery 2019
Annual Meeting in Orlando. This industry-focused plenary session will
feature executives from companies recognized for current and promising
technology platforms in robotic surgery.
Additionally, Mr. McNally will be participating among faculty in the
“Investing in Robotic Surgical Innovation” plenary session on Saturday,
June 22. This unique session will bring together healthcare experts
along with industry leaders and members of the investment community to
discuss the current landscape, future innovations, and to evaluate the
impact and value of robotic surgery. Titan’s Vice President of
Marketing, Sachin Sankholkar will participate in the panel session
addressing “Challenges of Building New Robots, Understanding the
Technological Challenges” on Friday, June 21. Titan Medical will be
present and showcase its new technology video at its booth in the
Exhibit Hall throughout the meeting.
Mr. McNally, said, “We are pleased to exhibit and honored to participate
as industry faculty at the Society of Robotic Surgery 2019 Annual
Meeting, where we will be among clinical and industry experts in the
field of robotic surgery. The SRS Annual Meeting continues to be an
exceptional venue for Titan to present and be recognized among robotic
surgery innovators. We look forward to sharing our vision and commitment
to advancing robotic surgery during our participation at this year’s
The Society of Robotic Surgery 2019 Annual Meeting is designed to be the
most comprehensive robotic surgery symposium, featuring internationally
renowned faculty who are dedicated experts in their fields of study.
About Titan Medical Inc.
Titan Medical Inc. is focused on computer-assisted robotic surgical
technologies for application in MIS. The Company is developing a
single-port robotic surgical system comprised of a surgeon-controlled
patient cart that includes a 3D high-definition vision system and
multi-articulating instruments for performing MIS procedures, and a
surgeon workstation that provides an advanced ergonomic interface to the
patient cart and a 3D endoscopic view inside the patient’s body. Titan
intends to initially pursue gynecologic surgical indications for use of
its single-port robotic surgical system.
For more information, please visit the Company’s website at www.titanmedicalinc.com.
This news release contains “forward-looking statements” which reflect
the current expectations of management of the Company’s future growth,
results of operations, performance and business prospects and
opportunities. Wherever possible, words such as “may”, “would”, “could”,
“will”, “anticipate”, “believe”, “plan”, “expect”, “intend”, “estimate”,
“potential for” and similar expressions have been used to identify these
forward-looking statements. These statements reflect management’s
current beliefs with respect to future events and are based on
information currently available to management. Forward-looking
statements involve significant risks, uncertainties and assumptions.
Many factors could cause the Company’s actual results, performance or
achievements to be materially different from any future results,
performance or achievements that may be expressed or implied by such
forward-looking statements, including, without limitation, those listed
in the “Risk Factors” section of the Company’s Annual Information Form
dated March 29, 2019 (which may be viewed at www.sedar.com).
Should one or more of these risks or uncertainties materialize, or
should assumptions underlying the forward-looking statements prove
incorrect, actual results, performance, or achievements may vary
materially from those expressed or implied by the forward-looking
statements contained in this news release. These factors should be
considered carefully, and prospective investors should not place undue
reliance on the forward-looking statements. Although the forward-looking
statements contained in the news release are based upon what management
currently believes to be reasonable assumptions, the Company cannot
assure prospective investors that actual results, performance or
achievements will be consistent with these forward-looking statements.